GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

MindMaze Therapeutics Holding MMTX.SW · CHF

Health Care · SIX · 🇨🇭 Switzerland

Compare

0.14

+0.89%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

MindMaze Therapeutics Holding — daily SIX:MMTX End of day
Market value
CHF 1.7m
Last close × shares
Volume
203.5k
Shares, 9 Nov 2026

About MindMaze Therapeutics Holding

Its shares trade on SIX under the ticker MMTX.SW. It has been listed since 19 September 2011. In the fiscal year to 31 December 2025, it reported revenue of CHF 642,000 and a net loss of CHF 9.9m. At that date it held total assets of CHF 51.5m and shareholders' equity of CHF 38.3m.

RELIEF THERAPEUTICS Holding AG is a clinical stage biotechnology company. The company is headquartered in Geneve, Geneve. The company went IPO on 2011-09-19. The Company’s objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need, as well as to focus on developing treatments for respiratory diseases. The company specializes in clinical-stage projects based on molecules of natural origin (peptides and proteins with a history of clinical use and either initial human activity with efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action in respiratory indications. RLF-100 is being investigated in two placebo-controlled U.S. phase 2b/3 clinical trials in respiratory deficiency due to COVID-19. Its RLF-100 is also used for pulmonary sarcoidosis. The firm is also involved in the clinical development of RLF-100 that is in planning stage for other indications in acute and chronic lung diseases.

Figures and description from our data supplier, not checked against the company's own report.

More about MindMaze Therapeutics Holding →

Latest on MindMaze Therapeutics Holding

Our reporting

We have not reported on MindMaze Therapeutics Holding yet.

Next results

15 Apr 2027

Due on 15 Apr 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is MindMaze Therapeutics Holding's ticker?

MindMaze Therapeutics Holding trades as MMTX.SW on SIX, under ISIN CH1251125998.

What was MindMaze Therapeutics Holding's last closing price?

0.14 on 9 Nov 2026. The figure is in CHF and is never converted.

When does MindMaze Therapeutics Holding next report results?

Results are expected on 15 Apr 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.